1. An overview of investigational Histone deacetylase inhibitors (HDACis) for the treatment of non-Hodgkin's lymphoma. (2nd June 2016) Authors: Apuri, Susmitha; Sokol, Lubomir Journal: Expert opinion on investigational drugs Issue: Volume 25:Number 6(2016:Jun.) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma. (April 2017) Authors: Zimmer, Lisa; Apuri, Susmitha; Eroglu, Zeynep; Kottschade, Lisa A.; Forschner, Andrea; Gutzmer, Ralf; Schlaak, Max; Heinzerling, Lucie; Krackhardt, Angela M.; Loquai, Carmen; Markovic, Svetomir N.; Joseph, Richard W.; Markey, Kelly; Utikal, Jochen S.; Weishaupt, Carsten; Goldinger, Simone M.; Son... Journal: European journal of cancer Issue: Volume 75(2017) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neoadjuvant and Adjuvant Therapies for Breast Cancer. Issue 10 (October 2017) Authors: Apuri, Susmitha Journal: Southern medical journal Issue: Volume 110:Issue 10(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗